To hear about similar clinical trials, please enter your email below
Trial Title:
Intraperitoneal Hyperthermic Chemotherapy in Epithelial Ovarian Carcinoma
NCT ID:
NCT00349505
Condition:
Epithelial Ovarian Carcinoma
Figo Stage IIIC
Conditions: Official terms:
Carcinoma
Ovarian Neoplasms
Carcinoma, Ovarian Epithelial
Conditions: Keywords:
previous treatment surgery + 6 cycles of platinum based chemotherapy
Study type:
Interventional
Study phase:
Phase 2
Overall status:
Unknown status
Study design:
Allocation:
Non-Randomized
Intervention model:
Single Group Assignment
Primary purpose:
Treatment
Masking:
None (Open Label)
Intervention:
Intervention type:
Procedure
Intervention name:
hyper thermic chemo + surgery
Summary:
Phase II to study results and morbidity of intra peritoneal hyper-thermic chemotherapy as
consolidation therapy in patients with FIGO stage IIIC epithelial ovarian carcinoma
treated by surgery and a total of 6 cycles of platinum based chemotherapy.
A second look operation is performed after treatment; during this second look secondary
cytoreductive surgery is accepted without bowel resection.If none or milimetric
peritoneal disease is obseved an intraperitoneal chemotherapy is achieve
Criteria for eligibility:
Criteria:
Inclusion Criteria:
epithelial ovarian carcinoma previous surgery + 6 cycles platinum based chemotherapy
- Exclusion Criteria:
- Patients ASA 3 patients with no residual tumor at first operation negative
microscopic second look
Gender:
Female
Minimum age:
18 Years
Maximum age:
65 Years
Healthy volunteers:
No
Locations:
Facility:
Name:
Institut Gustave Roussy
Address:
City:
Villejuif
Zip:
94800
Country:
France
Status:
Recruiting
Contact:
Last name:
Dominique ELIAS, MD,PhD
Phone:
00 33 014-211-5441
Email:
elias@igr.fr
Start date:
September 2004
Lead sponsor:
Agency:
Gustave Roussy, Cancer Campus, Grand Paris
Agency class:
Other
Source:
Gustave Roussy, Cancer Campus, Grand Paris
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT00349505
